|
English
|
正體中文
|
简体中文
|
0
|
|
???header.visitor??? :
52668644
???header.onlineuser??? :
676
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.title???
|
Showing items 414771-414780 of 2348617 (234862 Page(s) Totally)
<< < 41473 41474 41475 41476 41477 41478 41479 41480 41481 41482 > >>
View [10|25|50] records per page
| 嘉南藥理大學 |
2007-08 |
Expression of CDC25B in human spermatozoa.
|
Yen-Ni Teng; Chia-Ling Chung; Yung-Ming Lin; Hsien-An Pan; Rui-Wen Liao; Pao-Lin Kuo |
| 國立臺灣大學 |
1979 |
Expression of Cel 1 Gene in Col El Plasmid and Certain Hybrid Plasmids Derived from Eco R1 Treated Col El Vector
|
楊惠郎; Zubay, G.; Yang, Huey-Lang; Zubay, G. |
| 國立臺灣大學 |
2008 |
Expression of Cellular Inhibitor of Apoptosis Protein 1 in Oral Squamous Cell Carcinoma and Precancerous Lesions
|
張嘉銓; 余權航; 洪千雁; 張玉芳; 王逸平; 劉步遠; 郭儒銓; 郭英雄; 江俊斌; CHANG, CHIA-CHUAN; YU, CHUAN-HANG; HUNG, HSIEN-YEN; CHANG, JULIA YU-FONG; WANG, YI-PING; LIU, BU-YUAN; KUO, RU-CHENG; KUO, YING- SHIUNG; CHIANG, CHUN-PIN |
| 高雄醫學大學 |
2007 |
Expression of centrosomal proteins and Aurora family in meningioma and astrocytoma
|
洪純隆;劉安祥;洪義人 |
| 臺大學術典藏 |
2020-03-03T03:36:44Z |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
Huang S.-Y.; CHUNG-WU LIN; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
HWEI-FANG TIEN; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Lu H.-Y.; Chen Y.-C.; Wu S.-J.; Tang J.-L.; Lin H.-H.; Yao M.; Huang S.-Y.; Lin C.-W. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
MING YAO; Lin C.-W.; Lin H.-H.; Huang S.-Y.; Chou S.-J.; Chou W.-C.; Tsay W.; Chen C.-Y.; Hou H.-A.; Chen Y.-C.; Lu H.-Y.; Wu S.-J.; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2014 |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
SHANG-YI HUANG; Lin C.-W.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2021-02-05T06:29:33Z |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
Huang S.-Y.; Lin C.-W.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; Hou H.-A.; Chen C.-Y.; WEN-CHIEN CHOU; Tsay W.; Chou S.-J.; Tien H.-F. |
| 臺大學術典藏 |
2022-01-12T07:07:33Z |
Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma
|
Huang S.-Y.; Lin C.-W.; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Chen Y.-C.; Lu H.-Y.; HSIN-AN HOU; Chen C.-Y.; Chou W.-C.; Tsay W.; Chou S.-J.; Tien H.-F. |
Showing items 414771-414780 of 2348617 (234862 Page(s) Totally)
<< < 41473 41474 41475 41476 41477 41478 41479 41480 41481 41482 > >>
View [10|25|50] records per page
|
